In the US, Altretamine (altretamine systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Ovarian Cancer.
US matches:
- Altretamine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XX03
CAS registry number (Chemical Abstracts Service)
0000645-05-6
Chemical Formula
C9-H18-N6
Molecular Weight
210
Therapeutic Category
Antineoplastic agent
Chemical Name
1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-
Foreign Names
- Altretaminum (Latin)
- Altretamin (German)
- Altrétamine (French)
- Altretamina (Spanish)
Generic Names
- Altretamine (OS: USAN, BAN)
- Altrétamine (OS: DCF)
- Hexamethylmelamine (IS: WHO)
- NSC 13875 (IS)
- RB 1515 (IS)
- Altretamine (PH: USP 32)
Brand Names
- Hexalen
Eisai, United States; MGI, United States - Hexastat
ProStrakan, France
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment